Core Laboratories (NYSE:CLB – Get Free Report) issued an update on its fourth quarter earnings guidance on Wednesday morning. The company provided EPS guidance of $0.20-0.25 for the period, compared to the consensus EPS estimate of $0.24. The company issued revenue guidance of $128.5-135.5 million, compared to the consensus revenue estimate of $134.60 million. Core Laboratories also updated its Q4 2024 guidance to 0.200-0.250 EPS.
Core Laboratories Price Performance
NYSE CLB traded down $0.18 during trading on Wednesday, reaching $17.07. 590,211 shares of the company traded hands, compared to its average volume of 433,538. The company has a market cap of $800.58 million, a price-to-earnings ratio of 19.40, a P/E/G ratio of 1.08 and a beta of 2.36. The stock’s 50 day moving average price is $18.59 and its two-hundred day moving average price is $18.97. Core Laboratories has a 1-year low of $13.82 and a 1-year high of $25.13. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.68 and a current ratio of 2.39.
Core Laboratories (NYSE:CLB – Get Free Report) last issued its earnings results on Wednesday, July 24th. The oil and gas company reported $0.22 EPS for the quarter, beating the consensus estimate of $0.21 by $0.01. Core Laboratories had a net margin of 5.44% and a return on equity of 15.20%. The company had revenue of $130.58 million during the quarter, compared to analysts’ expectations of $132.85 million. During the same quarter in the previous year, the company posted $0.23 EPS. The business’s revenue for the quarter was up 2.1% compared to the same quarter last year. As a group, analysts anticipate that Core Laboratories will post 0.8 EPS for the current year.
Wall Street Analysts Forecast Growth
Get Our Latest Stock Analysis on CLB
About Core Laboratories
Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.
Featured Stories
- Five stocks we like better than Core Laboratories
- Are Penny Stocks a Good Fit for Your Portfolio?
- Chinese Stocks Cool Off: Time to Buy the Dip in These 2 Stocks?
- What Is WallStreetBets and What Stocks Are They Targeting?
- Goldman Sachs Highlights 3 Top Short Squeeze Stocks to Watch
- How to Choose Top Rated Stocks
- Walmart is Up 56% YTD, Is it Still a Top Consumer Staples Stock?
Receive News & Ratings for Core Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.